The study evaluates the clinical course and the development of systolic and diastolic left ventricular function in patients with chronic myocarditis with or without autoantibodies against cardiac myosin.
Currently, most cases of human myocarditis are thought to be of viral origin (1) (2) (3) (4) (5) . Viral ribonucleic acid (RNA) has been detected in the myocardium of patients with myocarditis and dilated cardiomyopathy (6 -8) . Although the exact pathogenetic mechanisms are only vaguely understood, an increasing body of evidence suggests that in the course of myocarditis, autoimmunological mechanisms may play an important role (9) . Several autoantibodies against human cardiac antigens have been identified in patients with myocarditis and dilated cardiomyopathy (10 -14) , including cardiac myosin (15, 16) . In vitro studies disclosed several possible pathogenetic mechanisms by which autoantibodies against cardiac antigens may influence cardiac function (17) , but only a few clinical studies have investigated the impact of anticardiac autoantibodies on clinical course and functional parameters of the patients (18, 19) . In patients with dilated cardiomyopathy, antimyosin autoantibodies (AMAAB) become undetectable in about 50% of the patients after one year (18) . In this study, persistence of AMAAB was associated with stable clinical conditions. To our knowledge, no studies are available that have investigated the impact of AMAAB on clinical outcome and changes of left ventricular function in patients with myocarditis.
Therefore, this study investigates the association of AMAAB with the clinical course and changes in left ventricular systolic and diastolic function in patients with chronic myocarditis.
METHODS

Patients.
Thirty-three patients with chronic myocarditis (20 men, 13 women, 47.4 Ϯ 12.7 years) were included in the study. Clinical symptoms of the patients at the time of presentation were systolic left ventricular dysfunction in 23 patients, angina pectoris in 7 patients, new rhythm disturbances in 6 patients and signs of congestive heart failure with preserved systolic left ventricular function suggesting diastolic dysfunction in 2 patients. All patients presented initially within six months of onset of symptoms. Eleven patients reported the presence of symptoms of upper respiratory tract infections or gastrointestinal symptoms before clinical presentation.
All patients underwent right and left heart catheterization including left ventriculography and right ventricular endomyocardial biopsy. Coronary artery disease was excluded in all patients by coronary angiography. Sera of all patients were analyzed for the presence of AMAABs. Myocarditis was diagnosed by histological and immunohistological analysis of endomyocardial biopsy specimen. Nineteen (58%) patients were treated with angiotensin-converting enzyme inhibitors, 21 (64%) patients with diuretics, 16 patients (45%) with digitalis, 8 (24%) patients with beta-adrenergic blocking agents, 16 (45%) patients with anticoagulants and 7 (21%) with antiarrythmic agents. No patient did receive specific, i.e., immunosuppressive, therapy. The diagnosis of chronic myocarditis was established in all patients by histologic or immunohistologic criteria in a second endomyocardial biopsy after six months, when right and left heart catheterization, left ventriculography and assessment of AMAAB were repeated.
Analysis of endomyocardial biopsy specimen. Endomyocardial biopsies were taken transvenously via the femoral approach from the right heart side of the interventricular septum. The endomyocardial biopsies were examined histologically according to the "Dallas Criteria" (20) . The histological sections were analyzed by light microscopy for evidence of myocardial necrosis, interstitial fibrosis and for the presence of lymphocytic infiltrates. Because the histological evaluation of myocardial biopsies is known to be difficult and affected by many problems (21, 22) including high interobserver variability (23) and sampling error (24) , this technique is regarded as rather insensitive for the diagnosis of myocarditis (25) . Therefore, the biopsy specimens were examined additionally with immunohistological techniques. Monoclonal antibodies directed against surface antigens of human lymphocytes (CD3, CD4, CD8) were used to detect and quantitate lymphocytic infiltrates in the myocardium (26 -29) . Additionally, using antibodies against the major histocompatibility antigens (MHC), the expression of MHC I and II antigens was analyzed. With these techniques, the diagnostic accuracy in the biopsies could be increased (30) and the interobserver variability could be minimized (31, 32) .
The biopsy specimens were classified as "acute myocarditis" when histological sections of endomyocardial biopsies revealed lymphocytic infiltrates in the neighborhood of myocardial necrosis (20) . "Borderline myocarditis" was diagnosed when lymphocytic infiltrates were present in histological sections without myocyte necrosis (20) (Fig. 1A) . When the immunohistological analysis revealed pathologically increased lymphocytic infiltrates (Ͼ2.0 lymphocytes/ high power field [32] ) and an increased expression of MHC I and II antigens, the biopsy was classified as "lymphocytic myocarditis" (Fig. 1B) .
The diagnosis of "chronic myocarditis" was based on the histological or immunohistological detection of lymphocytic infiltrates in the myocardium in the second biopsy six months after the initial evaluation.
Analysis of antimyosin autoantibodies. Sera of patients with myocarditis were analyzed for the presence of AMAAB as previously described (15) . Sera were taken on admission of the patients and immediately stored at Ϫ70°C. Analysis of AMAAB was done in batches. Human cardiac myosin was prepared according to Offer et al. (33) Left ventricular volumes were calculated using the "area-lengthmethod" (35) . Left ventricular pressures were plotted on a Versatec Printer-Plotter in 5 ms intervals with a paper speed of 100 mm/s. The time constant of diastolic relaxation tau was measured according to Raff and Glantz (36) . The constant of diastolic stiffness was calculated using a monoexponential model with variable asymptote (37) (38) (39) .
Statistical analysis.
Variables were analyzed by MannWhitney U test (two-sided). P values Ͻ0.05 were considered to indicate statistical significance.
RESULTS
Histological and immunohistological analysis of endomyocardial biopsies in patients with chronic myocarditis.
The findings in the endomyocardial biopsies are shown in Figure 2 . At baseline, no patient showed histological evidence of myocytolysis. "Borderline myocarditis" was diagnosed at baseline in six patients, additional immunohistological analysis demonstrated "lymphocytic myocarditis" in all 33 patients. Evidence of interstitial fibrosis was present in eight patients; the degree of fibrosis was not quantitated in the small biopsy specimen. After six months, the endomyocardial biopsy disclosed evidence of chronic myocarditis in all patients. Histologically, no patient had "acute myocarditis"; "borderline myocarditis" was diagnosed in 10 patients and "lymphocytic myocarditis" was demonstrated immunohistologically in 31 patients. Evidence of fibrosis was detected in 10 patients; in 3 of these patients, it was already present at baseline, and in 7 patients fibrosis was not detectable at baseline. AMAAB in patients with chronic myocarditis. At baseline, AMAAB were found in 17 (52%) patients (Fig. 3) . After six months AMAAB were still detectable in 13/17 (76%) initially antimyosin-autoantibody positive (AMAAB[ϩ]) patients. In 4/17 (24%) initially AMAAB(ϩ) patients, no AMAAB could be detected after six months. Sixteen (48%) patients were initially antimyosin-autoantibody negative (AMAAB[Ϫ]). After six months, all 16 patients had remained AMAAB(Ϫ); no patient had developed AMAAB.
Impact of AMAAB at baseline on clinical symptoms and changes of systolic and diastolic left ventricular function.
After six months, two initially AMAAB(ϩ) patients reported moderate clinical improvement of symptoms (New York Heart Association [NYHA] class), two initially AMAAB(ϩ) pa- 
DISCUSSION
Autoantibodies against cardiac myosin have been found in patients with myocarditis (15) and dilated cardiomyopathy (16) . These AMAAB are directed against alpha-and 
beta-cardiac myosin heavy chains (16) . At the time of diagnosis, these autoantibodies are not associated with specific clinical or diagnostic features (15, 40) . In patients with dilated cardiomyopathy, 52% of the patients who showed AMAAB at baseline, became antibody negative after one year and no initially antibody-negative patient became antibody-positive at follow-up (18) . This is in concordance with this study where 22% of the initially AMAAB(ϩ) patients with myocarditis had lost their autoantibodies after six months and no initially antibodynegative patient had developed AMAAB at follow-up.
AMAAB and left ventricular function.
This study is the first report that evaluates the time course of systolic and diastolic left ventricular function in patients with myocarditis and autoantibodies against cardiac antigens. In patients with histologically or immunohistologically diagnosed myocarditis, the presence of AMAAB is associated with less favorable development of systolic and diastolic left ventricular function during a six month follow-up period. The change in parameters of systolic left ventricular function (EF, SV, SVI) were significantly better in patients without AMAAB compared with AMAAB(ϩ) patients. This seems not to be due to different preload or afterload of the left ventricle in the two study groups as left ventricular enddiastolic pressure and systolic arterial pressure were not different between the groups at baseline and had not changed at follow-up. The development of diastolic left ventricular function was also different between AMAAB(ϩ) and AMAAB(Ϫ) patients. The constant of diastolic stiffness "b" was higher at follow-up in AMAAB(ϩ) patients compared with baseline, whereas "b" was lower compared with baseline in AMAAB(Ϫ) patients, i.e., the left ventricle in AMAAB(ϩ) patients became stiffer and less compliant than it did in AMAAB(Ϫ) patients. Left ventricular relaxation did not change throughout the study period in either group.
The pathophysiologic mechanisms responsible for the development of less compliant ventricles in patients with AMAAB are not clear. Patients with myocarditis show various degrees of interstitial fibrosis in the myocardium (41) . In patients with presumably chronic myocarditis, massive interstitial fibrosis has been found (42) . Therefore, it could be possible that in this study AMAAB(ϩ) patients had developed more fibrosis in six months than AMAAB(Ϫ) patients. However, no studies evaluating the time course of the development of interstitial fibrosis in patients with myocarditis are yet available. In this study, interstitial fibrosis could not be evaluated quantitatively in the small biopsy specimen. "Vascular turgor" (43) was not different in the two study groups. Other possible causes for increased chamber stiffness such as amyloidosis or myocardial edema cannot be ruled out in this study; however, they seem unlikely to be responsible for the observed changes in left ventricular stiffness.
AMAAB and clinical course of myocarditis and dilated cardiomyopathy. In this study, patients with chronic myocarditis and AMAAB reported no change in clinical symptoms after six months; patients without AMAAB reported slight improvement of symptoms. Caforio et al. (18) analyzed AMAAB and the clinical course in patients with dilated cardiomyopathy. Persistence of AMAAB was associated with milder symptoms at presentation and stable disease. In this study, the diagnosis of dilated cardiomyopathy was based only on histological analysis of the endomyocardial biopsy. The histological analysis alone of the endomyocardial biopsy is known to be difficult (21, 22) and affected by many problems including high "interobservervariability" (23) and sampling error (24) . Therefore, histological analysis alone is thought to be rather insensitive for the diagnosis of myocarditis (26 -29) . This study employs both histological and immunohistological analysis of the endomyocardial biopsy specimen. With these techniques, lymphocytic infiltrates could be detected in 48% of patients presenting with the clinical picture of dilated cardiomyopathy, whereas histological analysis alone found myocarditis in only 5% of patients (32) . Therefore, it cannot be ruled out (48) . Another possibility is the exposition of sequestered antigens to the immune system in the course of myocarditis. Intracellular proteins such as myosin are possibly exposed to the immunogenic cells, thus perpetuating the autoimmunologic process. This study shows that AMAAB are associated with less favorable development of left ventricular systolic and diastolic function in patients with chronic myocarditis. One possible explanation would be that in the two study groups different pathophysiologic mechanisms are responsible for the development of chronic myocarditis. In AMAAB(ϩ) patients, chronic myocarditis may be caused by autoimmunologic mechanisms, probably depending on genetic predisposition (49) , whereas in AMAAB(Ϫ) patients, other mechanisms like persistence of viral genome in the myocardium (8,50) may be responsible for the development of a chronic disease. In this case, the AMAAB could serve as a marker of an autoimmunologic process in the patients. Another explanation would be that in AMAAB(Ϫ) patients, autoantibodies against other cardiac antigens (10 -14) may be responsible for the development of chronic myocarditis and that these autoantibodies may have different effects on cardiac function (17, 19) . However, it cannot be overlooked that the AMAAB themselves may influence cardiac function via a yet unknown mechanism. In patients with myocarditis, in whom myocardial cell damage was studied by antimyosin scintigraphy, the presence of AMAAB seems to prevent the binding of the radioactively labeled AMAAB to the myocardium (51) . This suggests that the AMAAB in these patients may bind to epitopes in the heart and consequently may influence cardiac function.
Conclusions. This study shows that, in patients with chronic myocarditis, the presence of autoantibodies against cardiac myosin is associated with less favorable development of left ventricular systolic function and diastolic stiffness in the course of the disease.
